George Peoples, MD on Receiving Viagenpumatucel-L plus Nivolumab: Standard of Care? @HeatBiologics

George Peoples, MD of Heat Biologics @HeatBiologics discusses tumor antigen expression and survival of patients with previously-treated advanced NSCLC receiving viagenpumatucel-L plus nivolumab.

Read here: https://www.heatbio.com/news-media/news-releases/detail/660/heat-biologics-presents-positive-survival-benefit-for